ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MINISHA KOCHAR MD

Cardiovascular Disease

441

$18.1K

142
133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 28%

$41
Average prescription price

Avg: $67

ASHOK KRISHNASWAMI MD

Cardiovascular Disease

441

$18.5K

128
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 28%

$42
Average prescription price

Avg: $67

TAMARA HORWICH MD

Cardiovascular Disease

435

$27.7K

27
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 28%

$64
Average prescription price

Avg: $67

HOWARD BUCKLEY M.D.

Cardiovascular Disease

435

$16.7K

78
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 28%

$38
Average prescription price

Avg: $67

PATRICK MCGINTY MD

Cardiovascular Disease

434

$20K

71
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$46
Average prescription price

Avg: $67

LAWRENCE RAPHAEL MD

Cardiovascular Disease

415

$15K

97
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

4%
prescriptions for brand name drugs

Avg: 28%

$36
Average prescription price

Avg: $67

DAWN LOMBARDO DO

Cardiovascular Disease

397

$26.8K

67
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 28%

$67
Average prescription price

Avg: $67

MICHAEL BLUM MD

Cardiovascular Disease

390

$20.3K

59
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 28%

$52
Average prescription price

Avg: $67

WILLIAM DISCEPOLO M.D.

Cardiovascular Disease

369

$13.6K

87
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$37
Average prescription price

Avg: $67

MICHAEL LEE MD

Cardiovascular Disease

362

$28.8K

75
61 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 28%

$80
Average prescription price

Avg: $67

REBECCA DOANE MD

Cardiovascular Disease

358

$27.8K

128
116 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 28%

$78
Average prescription price

Avg: $67

NEIL TREISTER M.D.

Cardiovascular Disease

355

$17.9K

35
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 28%

$50
Average prescription price

Avg: $67

PRISCILLA HSUE MD

Cardiovascular Disease

345

$63.7K

42
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 28%

$185
Average prescription price

Avg: $67

HERBERT LEE MD

Cardiovascular Disease

323

$5,451

57
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

7%
prescriptions for brand name drugs

Avg: 28%

$17
Average prescription price

Avg: $67

ABDUL ABBASI MD

Cardiovascular Disease

313

$11.2K

48
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$36
Average prescription price

Avg: $67

JONATHAN TURNER M.D.

Cardiovascular Disease

281

$11.1K

111
99 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

46%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 28%

$39
Average prescription price

Avg: $67

SHAZIA HASAN M.D.

Cardiovascular Disease

277

$13.9K

51
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 28%

$50
Average prescription price

Avg: $67

PAUL TEIRSTEIN M.D.

Cardiovascular Disease

272

$41.7K

74
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 28%

$153
Average prescription price

Avg: $67

ARMEN AGHABEGIAN P.A.

Cardiovascular Disease

253

$5,290

96
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

6%
prescriptions for brand name drugs

Avg: 28%

$21
Average prescription price

Avg: $67

STEVEN STRICKER MD

Cardiovascular Disease

237

$12.3K

42
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 28%

$52
Average prescription price

Avg: $67

RALPH WESSEL MD

Cardiovascular Disease

237

$12.7K

31
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 28%

$54
Average prescription price

Avg: $67

ENRIQUE OSTRZEGA M.D.

Cardiovascular Disease

222

$19K

30
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 28%

$86
Average prescription price

Avg: $67

OLCAY AKSOY M.D.

Cardiovascular Disease

182

$34.2K

61
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 28%

$188
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank